Convergence Investment Partners’s AstraZeneca AZN Stock Holding History

Convergence Investment Partners’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-274	Closed	-$19K	–	355
2018 Q1	$19K	Buy	+274	New	+$19K	﹤0.01%	602
2015 Q1	–	Sell	-2,967	Closed	-$209K	–	362
2014 Q4	$209K	Sell	2,967 -77	-3%	-$5.51K	0.03%	336
2014 Q3	$217K	Buy	+3,044	New	+$223K	0.03%	336
2014 Q2	–	Sell	-3,786	Closed	-$246K	–	370
2014 Q1	$246K	Sell	3,786 -1,081	-22%	-$69.8K	0.04%	324
2013 Q4	$289K	Sell	4,867 -784	-14%	-$42.6K	0.05%	315
2013 Q3	$293K	Sell	5,651 -1,591	-22%	-$79.9K	0.06%	244
2013 Q2	$343K	Buy	+7,242	New	+$369K	0.09%	240

Other funds holding AZN

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Bank of America

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Capital International Investors

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return